Cargando…

S100 Proteins in Alzheimer’s Disease

S100 proteins are calcium-binding proteins that regulate several processes associated with Alzheimer’s disease (AD) but whose contribution and direct involvement in disease pathophysiology remains to be fully established. Due to neuroinflammation in AD patients, the levels of several S100 proteins a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cristóvão, Joana S., Gomes, Cláudio M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532343/ https://www.ncbi.nlm.nih.gov/pubmed/31156365 http://dx.doi.org/10.3389/fnins.2019.00463

Ejemplares similares

Distribution and Relative Abundance of S100 Proteins in the Brain of the APP23 Alzheimer’s Disease Model Mice
por: Hagmeyer, Simone, et al.
Publicado: (2019)

Zinc Binding to S100B Affords Regulation of Trace Metal Homeostasis and Excitotoxicity in the Brain
por: Hagmeyer, Simone, et al.
Publicado: (2018)

Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease
por: Cristóvão, Joana S., et al.
Publicado: (2016)

S100B chaperone multimers suppress the formation of oligomers during Aβ42 aggregation
por: Figueira, António J., et al.
Publicado: (2023)

Alzheimer’s disease and epilepsy: The top 100 cited papers
por: Zhang, Gui-Fen, et al.
Publicado: (2022)

Targeting S100B with Peptides Encoding Intrinsic Aggregation-Prone Sequence Segments
por: Cristóvão, Joana S., et al.
Publicado: (2021)

The neuronal S100B protein is a calcium-tuned suppressor of amyloid-β aggregation
por: Cristóvão, Joana S., et al.
Publicado: (2018)

S-100B Protein and Chronic Subdural Hematoma
por: Gelabert-González, Miguel, et al.
Publicado: (2013)

The impact of Alzheimer’s disease risk factors on the pupillary light response
por: Sparks, Sierra, et al.
Publicado: (2023)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
por: Sontag, Jean-Marie, et al.
Publicado: (2014)

S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis
por: Daini, Eleonora, et al.
Publicado: (2021)

In Response to Comments Made in “S100B Protein and Chronic Subdural Hematoma”
por: Thelin, Eric Peter, et al.
Publicado: (2013)

Serum levels of S100B and NSE proteins in Alzheimer's disease patients
por: Chaves, Márcia L, et al.
Publicado: (2010)

Association of the Protein-Quality-Control Protein Ubiquilin-1 With Alzheimer’s Disease Both in vitro and in vivo
por: Zhang, Can, et al.
Publicado: (2022)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia
por: Milleit, Berko, et al.
Publicado: (2016)

Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015)

Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese
por: Cheng, Zaohuo, et al.
Publicado: (2018)

Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease
por: d‘Errico, Paolo, et al.
Publicado: (2020)

Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus
por: Mesquita, Sandro D., et al.
Publicado: (2012)

Memory loss in Alzheimer's disease: are the alterations in the UPR network involved in the cognitive impairment?
por: Duran-Aniotz, Claudia, et al.
Publicado: (2014)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

The S100B/RAGE Axis in Alzheimer's Disease
por: Leclerc, Estelle, et al.
Publicado: (2010)

Editorial: The Involvement of NGF in the Alzheimer's Pathology
por: Cuello, A. Claudio
Publicado: (2019)

Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
por: Nalivaeva, Natalia N., et al.
Publicado: (2014)

Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
por: Gentier, Romina J., et al.
Publicado: (2015)

Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
por: Thal, Dietmar R.
Publicado: (2015)

Identification and immune characteristics of molecular subtypes related to protein glycosylation in Alzheimer’s disease
por: Ma, Zhaotian, et al.
Publicado: (2022)

Alzheimer's Disease and Anesthesia
por: Papon, Marie-Amélie, et al.
Publicado: (2011)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Rethinking Alzheimer’s Disease
por: de Mendonça, Alexandre
Publicado: (2012)

Alzheimer’s disease and the fornix
por: Oishi, Kenichi, et al.
Publicado: (2014)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

Propionate and Alzheimer’s Disease
por: Killingsworth, Jessica, et al.
Publicado: (2021)

Epigenetics in Alzheimer’s Disease
por: Gao, Xiaodie, et al.
Publicado: (2022)

Editorial: Metabolism in Alzheimer's Disease
por: Morris, Jill K., et al.
Publicado: (2022)

Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021)

Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer’s disease
por: Wang, Hongjie, et al.
Publicado: (2022)

Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability
por: Leal, Sónia S., et al.
Publicado: (2015)

Speaking in Alzheimer’s Disease, is That an Early Sign? Importance of Changes in Language Abilities in Alzheimer’s Disease
por: Szatloczki, Greta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7bu0lhhjf12e44ch6noip75is2